Edgewise Therapeutics, Inc. Common Stock

EWTXNASDAQ • USD
45.30 USD
↘ 0.63 (1.37%)🟢LIVE (AS OF 09:30 AM EST)
🟢Market: OPEN

Edgewise Therapeutics, Inc. Common Stock (EWTX) trades at $45.30 per share. The technical outlook is "Strong Buy" and the fundamental picture shows "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, exceptional Return on Equity (61.8%), a bullish Golden Cross on the moving averages and bullish moving average alignment. On the valuation side, EWTX appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$45.97
High?$46.87
Low?$42.48
Prev. Close?$45.93
Volume?6.7K
Avg. Volume?1.6M
VWAP?$45.67
Rel. Volume?0.00x
Bid / Ask
Bid?$33.77 × 100
Ask?$52.22 × 100
Spread?$18.45
Midpoint?$43.00
Valuation & Ratios
Market Cap?5.0B
Shares Out?109.5M
Float?70.5M
Float %?64.9%
P/E Ratio?4.98
P/B Ratio?3.08
EPS?$9.22
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The company's product candidates are Sevasemten, EDG-7500, EDG-003, and EDG-15400. Sevasemten is an orally administered small molecule designed to address the root cause of dystrophinopathies, including Duchenne muscular dystrophy (Duchenne) and Becker muscular dystrophy (Becker). The company's products are currently in different stages of their development, being developed to target key muscle proteins and modulators to address a broad array of muscle diseases.
Employees
133
Market Cap
5.0B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-03-26
Address
1715 38TH ST
BOULDER, CO 80301
Phone: 720-262-7002
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+3/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
50
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?21.57Safe
Confidence?52%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?18.01%High
Short Interest?12.7M
Days to Cover?9.6
Free Float70.5M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?12.30Strong
Quick Ratio?12.30Strong
Cash Ratio?0.48Low
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
89/100
P/E?
Peers
100
S&P
97
5.0CHEAP▾
P/B?
Peers
100
S&P
55
3.08FAIR▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-23.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
Peers
50
S&P
93
61.8%STRONG▾
ROA?
Peers
50
S&P
97
56.7%STRONG▾
Cash Flow & Enterprise
FCF?$-202277000
Enterprise Value?$5.0B
Fundamentals ratios updated end of day